Sunshine Biopharma Inc.

Sunshine Biopharma Inc. is a pharmaceutical company engaged in the research, development, and commercialization of medicines across therapeutic areas such as oncology and antivirals. Through its subsidiary Nora Pharma, the company offers generic prescription medications addressing cardiovascular health, central nervous system disorders, oncology, diabetes, and other conditions. It also operates a subsidiary named Sunshine Biopharma Canada, which develops and sells over-the-counter dietary supplements. In addition, Sunshine Biopharma conducts proprietary research programs focused on an mRNA-based therapy for liver cancer and a protease inhibitor targeting SARS Coronaviruses. Its customers include pharmacies and consumers.

The company's commercial generic drugs are marketed in Canada, primarily in Quebec, with smaller presences in Ontario, Alberta, and British Columbia. It distributes 71 generic prescription drugs and holds 22 additional candidates in development. Over-the-counter supplements are sold exclusively through the Canadian Amazon marketplace. The company maintains its principal executive offices in Fort Lauderdale, Florida.

Summary of the business section of Sunshine Biopharma's latest annual report, written by StockData.

“As of the date of this report, we have a total of 50 employees, all of whom are full-time.”